Evidence map›Paper›PMID 39534957›Full record

ReviewHypertension (Dallas, Tex. : 1979)2025

Mechanistic Insights Into Redox Damage of the Podocyte in Hypertension.

Daria V Ilatovskaya, Amanda Behr, Alexander Staruschenko, Gentzon Hall, Oleg Palygin

Abstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. L-Type Voltage-Gated CaMedical sciences (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Serine proteases and protease-activated receptors signaling in the kidney.American journal of physiology. Cell physiology · 2025
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daria V IlatovskayaDepartment of Physiology, Medical College of Georgia (D.V.I.), Augusta University, Augusta, GA.
Amanda BehrDepartment of Medical Illustration, College of Allied Health Sciences (A.B.), Augusta University, Augusta, GA.
Alexander StaruschenkoDepartment of Molecular Pharmacology and Physiology (A.S.), University of South Florida, Tampa, FL.ORCID 0000-0002-5190-8356
Gentzon HallDivision of Nephrology, Department of Internal Medicine, Duke University School of Medicine, Durham, NC (G.H.).ORCID 0000-0002-6866-9945
Oleg PalyginDivision of Nephrology, Department of Medicine (O.P.), Medical University of South Carolina, Charleston, SC.ORCID 0000-0002-3680-5527

Funding

The Impact of Obesity and Leptin on the Development of Immune System Dysfunction and Hypertension in Females with Systemic Lupus ErythematousU54HL169191 · NHLBI · AUGUSTA UNIVERSITY · PI Jennifer C Sullivan · 2023 to 2026
$7.4M
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity SupplementR01HL148114 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ILATOVSKAYA, DARIA · 2020 to 2024
$2.8M
Sexual dimorphisms and role of the cGAS-STING pathway in diabetic nephropathyR01DK135644 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI Alexander Staruschenko · 2023 to 2026
$2.0M
Role of basolateral K channels in renal salt handling and BP controlR01DK126720 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PALYGIN, OLEG · 2021 to 2024
$1.5M
Renal diabetic complications mediated by the PAR1 signaling in podocytesR01DK129227 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI PALYGIN, OLEG, STARUSCHENKO, ALEXANDER · 2022 to 2025
$1.3M
The Role of Interleukin-15 Receptor-alpha Variants in the Pathogenesis of FSGSK08DK111940 · NIDDK · DUKE UNIVERSITY · PI HALL, GENTZON · 2017 to 2021
$794k
American Heart Association-American Stroke Association 24TPA1283630BLRD VA I01 BX004024NHLBI NIH HHS R01 HL148114NHLBI NIH HHS U54 HL169191NIDDK NIH HHS K08 DK111940NIDDK NIH HHS L30 DK110930NIDDK NIH HHS R01 DK126720NIDDK NIH HHS R01 DK129227NIDDK NIH HHS R01 DK135644NIMHD NIH HHS L60 MD008562
6 · The paper itself

Abstract

Podocytes are specialized cells within the glomerular filtration barrier, which are crucial for maintaining glomerular structural integrity and convective ultrafiltration. Podocytes exhibit a unique arborized morphology with foot processes interfacing by slit diaphragms, ladder-like, multimolecular sieves, which provide size and charge selectivity for ultrafiltration and transmembrane signaling. Podocyte dysfunction, resulting from oxidative stress, dysregulated prosurvival signaling, or structural damage, can drive the development of proteinuria and glomerulosclerosis in hypertensive nephropathy. Functionally, podocyte injury leads to actin cytoskeleton rearrangements, foot process effacement, dysregulated slit diaphragm protein expression, and impaired ultrafiltration. Notably, the renin-angiotensin system plays a pivotal role in podocyte function, with beneficial AT2R (angiotensin receptor 2)-mediated nitric oxide (NO) signaling to counteract AT1R (angiotensin receptor 1)-driven calcium (Ca

Indexed as

HypertensionOxidation-ReductionOxidative StressPodocytesAnimalsHumansHypertension, RenalNephritisRenin-Angiotensin Systemalbuminuriahypertensionkidney diseasesnephrologypodocytes

Identifiers

PMID39534957
PMCPMC11655258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.